Influenza vaccination can avert 32.9% to 41.5% of cases during seasonal outbreaks when the vaccine has 40% effectiveness, according to an agent-based modeling study of nearly 1.2 million simulated individuals. While vaccinated people gain the most direct protection, those who are unvaccinated also experience significant direct and indirect benefits, highlighting the ongoing importance of flu shots.
Image Credit: Seventyfour | stock.adobe.com
The study, which used the FRED simulation platform, modeled flu transmission across social networks like households, schools, and workplaces. It examined scenarios with transmission rates (Rt) between 1.43 and 1.88 and vaccine effectiveness from 40% to 60%. This detailed simulation shows how vaccination campaigns impact community immunity and underscores the critical role of pharmacists as community leaders.
Community Health and Pharmacy’s Role
While vaccinated individuals experienced a greater reduction in attack rates, unvaccinated people still saw substantial indirect protection, with attack rate ratios for unvaccinated versus vaccinated individuals ranging from 1.43 to 1.73. Research also indicates that prioritizing childhood vaccinations significantly lowers overall flu transmission. These findings reinforce that pharmacists, by promoting vaccine uptake, are vital in strengthening herd immunity and public health.
A 2013 survey in Canada found that 92% of patients were highly satisfied with flu shots administered by pharmacists, and 28% reported they would not have received the vaccine without pharmacy access. Further research, including a systematic review and meta-analysis, confirms that pharmacist involvement consistently increases immunization rates. A U.S. modeling analysis projected that incorporating pharmacies into flu vaccination campaigns could prevent millions of cases and generate considerable economic savings. These data collectively demonstrate that pharmacies enhance access and satisfaction while delivering tangible population-level benefits.
The modeling also revealed that when transmissibility (Rt) exceeds approximately 2.0, indirect protection from vaccines becomes minimal. In such high-transmission situations, pharmacists should advocate for supplementary public health measures like masking, social distancing, and antiviral guidance to bolster community protection.
Economic Impact and Pharmacy Recommendations
Economic analyses highlight that pharmacy-based vaccination programs are cost-effective. One U.S. study projected that expanding pharmacy vaccination efforts could prevent 16.5 million flu cases, leading to up to $70 billion in productivity gains and healthcare savings. Organizations that support pharmacy-based immunizations consistently point to their high societal and economic value.
Pharmacists should actively promote influenza vaccine uptake by leveraging the convenience of community pharmacy settings. Higher vaccination coverage directly reduces the overall flu burden and strengthens herd immunity. Pharmacists are key in educating patients about both personal protection and the broader community benefits of vaccination, thereby boosting acceptance. They should tailor outreach strategies to seasonal variations in vaccine effectiveness, emphasizing that even moderate efficacy provides significant public health advantages.
The analysis confirms that influenza vaccination offers both direct and indirect benefits, particularly during seasons with moderate transmission. Pharmacies are crucial in maximizing these benefits through accessible services, clear communication, and supportive policies. By increasing year-round vaccination awareness, promoting layered protection during peak transmission periods, and maintaining consistent outreach, pharmacists can substantially decrease flu-related illnesses, deaths, and associated costs.
REFERENCES
-
Krauland MG, Mandell A, Roberts MS. Estimated Burden of Influenza and Direct and Indirect Benefits of Influenza Vaccination. JAMA Netw Open. 2025;8(7):e2521324. doi:10.1001/jamanetworkopen.2025.21324
-
Williams KV, Krauland MG, Nowalk MP, et al. Increasing child vaccination coverage can reduce influenza cases across age groups: an agent-based modeling study. J Infect. 2025. doi:10.1016/j.jinf.2025.03.012
-
Papastergiou J, Folkins C, Li W, Zervas J. Community pharmacist-administered influenza immunization improves patient access to vaccination. Can Pharm J (Ott). 2014;147(6):359-365. doi:10.1177/1715163514552557
-
Murray E, Bieniek K, Del Aguila M, et al. Impact of pharmacy intervention on influenza vaccination acceptance: a systematic literature review and meta-analysis. Int J Clin Pharm. 2021;43(5):1163-1172. doi:10.1007/s11096-021-01250-1
-
Bartsch SM, Taitel MS, DePasse JV, et al. Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic. Vaccine. 2018;36(46):7054-7063. doi:10.1016/j.vaccine.2018.09.040
-
FIP. Funding models, economic and societal impact of pharmacy‑based vaccination: Executive summary. International Pharmaceutical Federation; 2024.
